Pharmaceuticals

Healthcare market robust – brands prosper while Chinese filings dominate: exclusive data analysis

In our latest industry data report, we explore the thriving and evolving healthcare industry. Our in-depth analysis reveals the trends driving this evolution, while also analysing key trademark filing statistics in this space.

Read more

Mankind Pharma Limited wins MANKIND dispute

A court has granted an ex parte order with costs against Mankind Merchandise Private Limited due to the plaintiff’s prior user and proprietary status and defendant's lack of proper justification for adopting and using the MANKIND mark.

Read more

EU General Court finds no genuine use of FEMIBION mark for pharmaceuticals

The EU General Court has annulled an EU Intellectual Property Office Board of Appeal decision, instead holding that registration of the EU word mark FEMIBION does not cover pharmaceutical preparations and instead covers only dietetic substances.

Read more

MULTIPHARMA held to be similar to MUNDIPHARMA

The EU General Court has reversed the EU Intellectual Property Office First Board of Appeal’s judgment that there was no likelihood of confusion between the marks MUNDIPHARMA and MULTIPHARMA based on conceptual differences.

Read more

IMMUNOSTAD invalidation appeal dismissed

The First Chamber of the General Court recently dismissed an appeal brought by Stada Arzneimittel AG against the EU Intellectual Property Office Board of Appeal’s decision to invalidate the mark IMMUNOSTAD for goods in Class 5.

Read more

Department of Justice memo plunges future of marijuana brands into uncertainty

The Trump administration has signalled a U-turn on the federal marijuana enforcement policy. Experts tell World Trademark Review why it matters for brands in the sector.

Read more

Valuing the monarchy, a counterfeiting crackdown and avoiding brand backlashes: news round-up

In our latest news round-up, we report on a new collaboration that aims to leave counterfeiters with “nowhere to hide”, examine Brand Finance’s research into the brand value of the British monarchy, and much more.

Read more

China pledges IP cooperation, Kanye West trademark fuels rumours, takeaways from INTA Leadership Meeting: news round-up

In the latest round-up, we look at some takeaways from the recent International Trademark Association Leadership Meeting, China’s latest pledge to increase cooperation over IP rights, and much more.

Read more

KIPO calls out Chinese plagiarism, USPTO rule making, reality show trademark protection and pugs in Prada: news round-up

In our latest round-up, we look at the fallout from Kid Rock’s latest tour announcement, how the Korean IP Office is speaking out on behalf of domestic brands, and much more.

Read more

Healthcare & Life Sciences Team of the Year: Novartis Pharma

When asked what has been keeping the team busy over the past 12 months, Novartis Pharma’s global head of trademarks and domain names presents a lengthy list.

Read more

Pharmaceutical brands in the Americas: practical strategies for a fast-moving sector

Experts from Canada, the United States and Venezuela discuss cutting-edge strategies for the creation, protection and exploitation of brands in the pharmaceutical industry.

Read more

The costs of counterfeiting: an exemplary study of the pharmaceutical industry

In order to take concrete steps to overcome the issues that counterfeiting presents, it is first necessary to understand the full scope of the phenomenon.

Read more

Procedures and strategies for pharmaceutical brands: Turkey

Pharmaceutical trademarks are governed by Decree-Law 556 on the Protection of Trademarks. That means an availability search should be conducted in the official database of the Turkish Patent Institute to reduce the risk of refusal or infringement.

Read more

Big changes in the pharmaceutical sector as leading brands flourish

A deep dive into key data about the pharmaceuticals sector suggests that over-regulation and availability of skills and technology remain key challenges; while the leading brands continue to rise in value, most are still filing in single classes only.

Read more

Big changes in the pharmaceutical sector as leading brands flourish: exclusive data analysis

In this week’s data report, we turn the spotlight on the sprawling pharmaceutical sector. We look at how the sector is being affected by political pressures, and identify the developments that are driving change.

Read more
Close

Register for more free content

  • Read more World Trademark Review blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 71